Table of Contents
The Global Injectable Drug Delivery Market accounted for $26.8 billion in 2014 and is expected to grow at a CAGR of 13.9% to reach $76.1 billion by 2022. The factors driving the injectable drug delivery market include rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices. Chronic disease rates are increasing at 14% each year. In 2012, 63% of the deaths across the world were due to chronic diseases. However, factors such as needlestick injuries are inhibiting the market growth. According to World Health Report 2002, more than 35% of Hepatitis B, around 40% of Hepatitis C and about 4% of HIV/AIDS in Health-Care Workers around the world are due to needlestick injuries. Lack of access to or failure to use appropriate personal protective equipment can cause needlestick injuries.
Acceptance of auto-injectors under insurance reimbursement by governments is further encouraging patients to switch from manual injections and prefilled syringes to auto-injectors, thereby boosting the market for auto-injectors. North America commanded the largest share dominated by the the United States in 2014. The Asia Pacific market is expected to exhibit the highest CAGR during the forecast period. The high incidence of target diseases such as diabetes in promising economies such as China and India is one of the significant market driver. In Asia Pacific, China and India are anticipated to be the fastest-growing injectable drug delivery markets. High prevalence of anaphylaxis in New Zealand and Australia is one of the major factors to fuel the growth of auto-injectors market during the forecast period in the region.
Some of the prominent players in injectable drug delivery market include Baxter International Inc., Becton Dickinson & Company, Eli Lilly and Company, Novo Nordisk, Terumo Corporation and Elcam.
Types of Injectable Drug Deliveries Covered:
• Auto injectors
• Pen Injectors
• Needle-Free Injectors
• Prefilled Syringes
• Safety Syringes
Application Types Covered:
• Autoimmune Diseases
• Metabolic Diseases
• Emergency Medicine
• North America
• Asia Pacific
o New Zealand
o Rest of Asia
• Rest of the World
o Latin America
o Middle East
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
North America Facial Injectables Market: Overview This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive ...
The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period. The increase ...
The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report ...